MARKET

ABPO

ABPO

ABPRO HLDGS INC
OTCPK
0.265
-0.257
-49.21%
Closed 15:51 02/23 EST
OPEN
0.410
PREV CLOSE
0.522
HIGH
0.440
LOW
0.260
VOLUME
402.06K
TURNOVER
126.90K
52 WEEK HIGH
27.90
52 WEEK LOW
0.260
MARKET CAP
720.09K
P/E (TTM)
-0.0109
1D
5D
1M
3M
1Y
5Y
1D
*News On Abpro Holdings Inc. (ABP) Now Under ABPO
Dow Jones · 13h ago
Weekly Report: what happened at ABP last week (0216-0220)?
Weekly Report · 1d ago
Abpro Holdings Faces Nasdaq Delisting, Plans Appeal
TipRanks · 3d ago
Nasdaq Orders Abpro Holdings Delisting for Minimum Equity Noncompliance
Reuters · 3d ago
Weekly Report: what happened at ABP last week (0209-0213)?
Weekly Report · 02/16 09:13
Is Abpro Holdings Inc Gaining or Losing Market Support?
Benzinga · 02/12 15:00
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/12 12:05
Why Fastly Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/12 09:31
More
About ABPO
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Webull offers ABPRO Holdings Inc stock information, including OTCPK: ABPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABPO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABPO stock methods without spending real money on the virtual paper trading platform.